An interventional study of Mindfulness-based Dance/Movement Therapy in Dementia Caregiver, sponsored by Drexel University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Drexel University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,051 studies in Dementia with a site in United States — 211 open to participants now, 276 under way, 15 of them phase 3. Dementia · United States.
Among the 1,051 studies in Dementia with a site in United States, this one is the 619th largest by enrollment of the 846 interventional ones that give a count, is one of 78 that started in 2024, is one of 562 with no phase, reaches primary completion later than 74 of the 275 other live ones, and was the 1,045th registered.
2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.
Browse Dementia studies →211 of the 1,051 studies in Dementia with a site in United States are open now. Recruiting first, the newest first:
University of Nebraska · Sites in United States
Ages 50+ · Women only · Healthy volunteers
University of Pittsburgh · Sites in United States
Ages 65+
The University of Texas Medical Branch, Galveston · Sites in United States
Ages 50–100 · Healthy volunteers
Weill Medical College of Cornell University · Sites in United States
Ages 21+ · Healthy volunteers
The Cleveland Clinic · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,051 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 73 · Phase 2 146 · Phase 3 79 · Phase 4 33
First in 1981; this study’s year is marked. 78 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 36 is below the median of 90 across 1,761 interventional studies indexed under Dementia.
Median enrollment 93 across the 846 interventional studies, 200 across the 200 observational. Of the 715 that completed or were terminated, 309 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
191 of 1,051 have an industry lead sponsor. The 10 most frequent:
Drexel University is the lead sponsor of 113 studies on the registry; 16 are open to participants now.
Drexel University has 5 studies filed under Dementia — fewer than ten, so there is no comparison to draw.
107 of the studies in Dementia with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05543681IGC Pharma, LLCClinical Trial on Agitation in Alzheimer's Dementia | 2026-11 |
| NCT07430371Rendever, Inc.Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support (VR-CARES) | 2026-11 |
| NCT06095284Virginia Commonwealth UniversityPrescribing Trends and Associated Outcomes of Antiepileptic Drugs in US Nursing Homes Surrounding the COVID-19 Pandemic | 2026-11-30 |
| NCT06298474Hopeful AgingThe BRAIN App (Phase 2 SBIR) | 2026-11-30 |
| NCT07859865Drexel UniversityMindfulness-based Movement Therapy for Persons With Dementia and Family Caregivers | 2026-11-30 |
Add all 107 to your calendar (.ics) → With an account.
Among the 1,051 studies in Dementia with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to investigate the feasibility and acceptability of a novel intervention, the CARE-MOVE program, which combines mindfulness-based dance/movement therapy (M-DMT), psychoeducation, and a support group for dementia care partners. The study also aims to provide proof of concept for the potential effects of the intervention on reducing stress, improving psychological well-being, and enhancing the caregiving relationship.
Specific Aim 1: To examine the feasibility and acceptability of the online CARE-MOVE program for dementia care partners.
The feasibility and acceptability of a 10-week online CARE-MOVE program will be evaluated among dementia care partners (n = 36). The program integrates M-DMT, psychoeducation, and support group components. Feasibility and acceptability outcomes will include enrollment, retention, protocol adherence, program satisfaction, perceptions of program components, barriers to engagement, and adverse events. Findings will be used to refine and optimize the intervention protocol for future efficacy testing in a larger randomized controlled trial.
Specific Aim 2: To establish proof of concept for the CARE-MOVE intervention in reducing stress, improving psychological well-being, and enhancing the caregiving relationship among dementia care partners.
Preliminary intervention effects will be examined with respect to stress, psychological well-being, caregiving burden, and the caregiving relationship. This exploratory evaluation is intended to generate initial evidence regarding the potential benefits of CARE-MOVE and to inform the design of future efficacy studies.
The study hypotheses are that participation in CARE-MOVE will be associated with (a) decreased stress, (b) improved psychological well-being, and (c) enhanced caregiving relationships among dementia care partners.
Specific Aim 3: To characterize how dementia reshapes embodied communication and connection within the caregiving relationship.
Changes in embodied and nonverbal relational processes, including touch, proximity, movement coordination, and co-regulation, will be examined across the caregiving trajectory. Care partners' experiences of these changes will also be explored, including how shifts in embodied communication and connection relate to ambiguous loss, identity change, and grief. Findings will identify intervention-relevant targets and inform refinement of the existing CARE-MOVE program.
The criteria were revised on the registry on Oct 8, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to the CARE-MOVE arm will receive a 10-week online mindfulness-based dance/movement therapy program for dementia care partners. They will attend weekly 70-minute group sessions incorporating movement, mindfulness-based embodied practices, music, sensory exploration, creative self-expression, and peer support. Sessions are designed to support emotional awareness and regulation, empathy, nonverbal communication, adaptive coping, self-compassion, and the caregiving relationship.
Behavioral: Mindfulness-based Dance/Movement Therapy
CARE-MOVE is a 10-week, synchronous online mindfulness-based dance/movement therapy intervention tailored for dementia care partners. Mindfulness principles are integrated into embodied and movement-based practices rather than taught as a separate comprehensive mindfulness curriculum. The intervention combines structured, self-directed, and interactive dance/movement, music, mindful meditation, sensory exploration, creative self-expression, and social support. The program progresses through five stages: emotional awareness and articulation, emotional expression and reciprocal attunement, empathy, affect modulation, and rhythmic synchrony.
Also known as: CARE-MOVE
Intervention Adherence
Intervention adherence will be assessed as the percentage of enrolled participants who attend at least 8 of the 10 CARE-MOVE sessions. The prespecified feasibility benchmark is that more than 80% of participants will complete at least 8 sessions.
Time frame: Through completion of the 10-week intervention
Participant Retention
Retention will be assessed as the percentage of enrolled participants who complete the 10-week CARE-MOVE intervention. Reasons for withdrawal or discontinuation will also be recorded. The prespecified benchmark is a dropout rate of 20% or less.
Time frame: Through completion of the 10-week intervention
Feasibility of Intervention Measure (FIM) Score
Perceived intervention feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM). Items are rated on a 5-point Likert scale from 1 (completely disagree) to 5 (completely agree), with higher scores indicating greater perceived feasibility. The protocol specifies a feasibility benchmark based on the summed FIM score.
Time frame: Post-intervention, approximately 10 weeks after baseline
Treatment Satisfaction
Treatment satisfaction will be assessed using participant ratings of the intervention structure and content on a 5-point Likert scale ranging from 1 (not very satisfied) to 5 (very satisfied). Higher scores indicate greater satisfaction. The prespecified benchmark is a mean rating greater than 3.5.
Time frame: Post-intervention, approximately 10 weeks after baseline
Perceived Stress
Perceived stress will be assessed using the 10-item Perceived Stress Scale (PSS-10), which assesses the extent to which participants perceive their lives as unpredictable, uncontrollable, and overwhelming. Items are rated on a 5-point frequency scale; higher scores indicate greater perceived stress.
Time frame: Baseline, post-intervention at 10 weeks, and 3-month follow-up
Caregiver distress related to dementia-related behaviors
Caregiver distress associated with dementia-related behaviors will be assessed using the Revised Memory and Behavior Problems Checklist. The Reaction component assesses how much each reported behavior bothers or upsets the caregiver, with higher scores indicating greater caregiver distress.
Time frame: Baseline, post-intervention at 10 weeks, and 3-month follow-up
Depressive symptoms
Depressive symptoms will be assessed using the 20-item CES-D. Items are rated from 0 to 3 based on symptom frequency during the past week. Total scores range from 0 to 60, with higher scores indicating greater depressive symptoms.
Time frame: Baseline, post-intervention at 10 weeks, and 3-month follow-up
Psychological well-being
Psychological well-being will be assessed using the 5-item WHO-5 Well-Being Index. Items assess positive mood, vitality, and general interest. Higher scores indicate greater psychological well-being.
Time frame: Baseline, post-intervention at 10 weeks, and 3-month follow-up
Caregiver-care recipient relationship quality
Relationship quality will be assessed using the 14-item Quality of Carer-Patient Relationship measure, which evaluates aspects of the current caregiver-care recipient relationship such as closeness, similarity of views, and getting along. Items are rated on a five-point scale and summed to produce a total score ranging from 14 to 70. Higher scores indicate better relationship quality and therefore a better outcome.
Time frame: Baseline, post-intervention at 10 weeks, and 3-month follow-up
Interpersonal mindfulness
Interpersonal mindfulness will be assessed using the 19-item Interpersonal Mindfulness Questionnaire. The measure assesses detachment from the mind, body-anchored presence, attention to and awareness of another person, and mindful responding. Items are rated from 1 (not at all) to 5 (very much), with higher scores indicating greater interpersonal mindfulness.
Time frame: Baseline, post-intervention at 10 weeks, and 3-month follow-up
Sleep disturbance
Sleep disturbance will be assessed using the 4-item PROMIS Sleep Disturbance 4a measure, which assesses perceived sleep quality, depth, and restoration. Items have five response options. Higher scores indicate greater sleep disturbance
Time frame: Baseline, post-intervention at 10 weeks, and 3-month follow-up
Plan to share: No
Started Apr 2024 (actual). Primary completion is estimated for Nov 2026, 31 months after the start.
Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 31 months is above that.
Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.